Even if you were to exclude the R&D rebate, it looks like the company is getting quite close towards cashflow breakeven. The short term debt's also been fully repaid during the quarter.
EHS remains on track for $1.5m EBITDA, whilst Sofihub conversion is abit slower but otherwise growth is still very strong yoy.
Overall looks quite good to me.
Ann: CTQ Q3-FY24 ACTIVITIES REPORT & APPENDIX 4C, page-2
Add CTQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.062M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 720081 | 1.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.4¢ | 500000 | 1 |
View Market Depth
| Last trade - 16.12pm 03/06/2024 (20 minute delay) ? |
| CTQ (ASX) Chart |
Day chart unavailable